Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health

被引:119
作者
Dilger, Karin [2 ]
Hohenester, Simon [1 ]
Winkler-Budenhofer, Ursula [3 ]
Bastiaansen, Barbara A. J. [1 ]
Schaap, Frank G. [1 ]
Rust, Christian [3 ]
Beuers, Ulrich [1 ]
机构
[1] Acad Med Ctr, Dept Gastroenterol & Hepatol, Tytgat Inst Liver & Intestinal Res, NL-1100 DE Amsterdam, Netherlands
[2] Dr Falk Pharma GmbH, Freiburg, Germany
[3] Univ Munich, Klinikum Grosshadern, Dept Med 2, D-8000 Munich, Germany
关键词
Bile; Biotransformation; Cholestasis; Clinical trial; Drug transport; PRIMARY SCLEROSING CHOLANGITIS; BIOCHEMICAL RESPONSE; ULCERATIVE-COLITIS; CYTOCHROME-P450; 3A; P-GLYCOPROTEIN; HCO3-UMBRELLA; LIVER; HUMANS; CHOLESTASIS; METABOLISM;
D O I
10.1016/j.jhep.2012.02.014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background & Aims: Ursodeoxycholic acid (UDCA) exerts anticholestatic, antifibrotic and antiproliferative effects in primary biliary cirrhosis (PBC) via mechanisms not yet fully understood. Its adequate biliary enrichment is considered mandatory for therapeutic efficacy. However, precise determination of biliary enrichment of UDCA is not possible in clinical practice. Therefore, we investigated (i) the relationship between biliary enrichment and plasma pharmacokinetics of UDCA, (ii) the effect of UDCA on plasma and biliary bile acid composition and conjugation patterns, and (iii) on the intestinal detoxification machinery in patients with PBC and healthy controls. Methods: In 11 PBC patients and 11 matched healthy subjects, cystic bile and duodenal tissue were collected before and after 3 weeks of administration of UDCA (15 mg/kg/day). Extensive pharmacokinetic profiling of bile acids was performed. The effect of UDCA on the intestinal detoxification machinery was studied by quantitative PCR and Western blotting. Results: The relative fraction of UDCA and its conjugates in plasma at trough level[x] correlated with their biliary enrichment[y] (r = 0.73, p = 0.0001, y = 3.65 + 0.49x). Taurine conjugates of the major hydrophobic bile acid, chenodeoxycholic acid, were more prominent in bile of PBC patients than in that of healthy controls. Biliary bile acid conjugation patterns normalized after treatment with UDCA. UDCA induced duodenal expression of key export pumps, BCRP and P-glycoprotein. Conclusions: Biliary and trough plasma enrichment of UDCA are closely correlated in PBC and health. Taurine conjugation may represent an adaptive mechanism in PBC against chenodeoxycholic acid-mediated bile duct damage. UDCA may stabilize small intestinal detoxification by upregulation of efflux pumps. (C) 2012 Published by Elsevier B.V. on behalf of the European Association for the Study of the Liver.
引用
收藏
页码:133 / 140
页数:8
相关论文
共 36 条
[1]
[Anonymous], 2009, J HEPATOL, V51, P237
[2]
BATTA AK, 1993, AM J GASTROENTEROL, V88, P691
[3]
Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans [J].
Becquemont, Laurent ;
Glaeser, Hartmut ;
Drescher, Siegfried ;
Hitzl, Monika ;
Simon, Nicolas ;
Murdter, Thomas E. ;
Heinkele, Georg ;
Hofmann, Ute ;
Schaefer, Christian ;
Burk, Oliver ;
Verstuyft, Celine ;
Eichelbaum, Michel ;
Fromm, Martin F. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (05) :449-460
[4]
Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis [J].
Beuers, Ulrich .
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (06) :318-328
[5]
The Binary HCO3- Umbrella: A Unifying Hypothesis on Pathogenetic and Therapeutic Aspects of Fibrosing Cholangiopathies [J].
Beuers, Ulrich ;
Hohenester, Simon ;
Wenniger, Lucas J. Maillette de Buy ;
Kremer, Andreas E. ;
Jansen, Peter L. M. ;
Elferink, Ronald P. J. Oude .
HEPATOLOGY, 2010, 52 (04) :1489-1496
[6]
Medical Treatment of Primary Sclerosing Cholangitis: A Role for Novel Bile Acids and other (post-)Transcriptional Modulators? [J].
Beuers, Ulrich ;
Kullak-Ublick, Gerd A. ;
Pusl, Thomas ;
Rauws, Erik R. ;
Rust, Christian .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2009, 36 (01) :52-61
[7]
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis [J].
Corpechot, Christophe ;
Abenavoli, Ludovico ;
Rabahi, Nabila ;
Chretien, Yves ;
Andreani, Tony ;
Johanet, Catherine ;
Chazouilleres, Olivier ;
Poupon, Raoul .
HEPATOLOGY, 2008, 48 (03) :871-877
[8]
CROSIGNANI A, 1991, HEPATOLOGY, V14, P1000, DOI 10.1002/hep.1840140609
[9]
No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis [J].
Dilger, K ;
Denk, A ;
Heeg, MHJ ;
Beuers, U .
HEPATOLOGY, 2005, 41 (03) :595-602
[10]
Guidance for Industry, BIOAN METH VAL